$46.35
3.78%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US05370A1088
Symbol
RNA

Avidity Biosciences Inc Stock price

$46.35
+12.82 38.23% 1M
+15.82 51.82% 6M
+17.27 59.39% YTD
+3.50 8.16% 1Y
+25.72 124.67% 3Y
+17.35 59.83% 5Y
+17.85 62.63% 10Y
+17.85 62.63% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+1.69 3.78%
ISIN
US05370A1088
Symbol
RNA
Industry

Key metrics

Basic
Market capitalization
$6.0b
Enterprise Value
$4.8b
Net debt
positive
Cash
$1.2b
Shares outstanding
120.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
555.7 | 866.9
EV/Sales
445.5 | 694.9
EV/FCF
negative
P/B
5.0
Financial Health
Equity Ratio
91.1%
Return on Equity
-22.6%
ROCE
-42.3%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$10.7m | $6.9m
EBITDA
$-518.7m | $-559.3m
EBIT
$-521.8m | $-551.9m
Net Income
$-455.7m | $-488.5m
Free Cash Flow
$-502.7m
Growth (TTM | estimate)
Revenue
1.2% | -36.9%
EBITDA
-83.5% | -48.7%
EBIT
-83.0% | -45.7%
Net Income
-80.5% | -51.6%
Free Cash Flow
-216.3%
Margin (TTM | estimate)
Gross
-
EBITDA
-4,834.9% | -8,130.7%
EBIT
-4,863.3%
Net
-4,247.8% | -7,101.6%
Free Cash Flow
-4,685.4%
More
EPS
$-3.5
FCF per Share
$-4.2
Short interest
12.7%
Employees
391
Rev per Employee
$30.0k
Show more

Is Avidity Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Avidity Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Avidity Biosciences Inc forecast:

21x Buy
95%
1x Hold
5%

Analyst Opinions

22 Analysts have issued a Avidity Biosciences Inc forecast:

Buy
95%
Hold
5%

Financial data from Avidity Biosciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
11 11
1% 1%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 122 122
89% 89%
1,138%
- Research and Development Expense 410 410
77% 77%
3,825%
-519 -519
84% 84%
-4,834%
- Depreciation and Amortization 3.05 3.05
22% 22%
28%
EBIT (Operating Income) EBIT -522 -522
83% 83%
-4,863%
Net Profit -456 -456
81% 81%
-4,247%

In millions USD.

Don't miss a Thing! We will send you all news about Avidity Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avidity Biosciences Inc Stock News

Positive
The Motley Fool
17 days ago
Avidity (RNA) Q2 Revenue Jumps 88%
Neutral
PRNewsWire
17 days ago
Aligned with FDA on del-brax accelerated and full approval pathways for FSHD, reported positive topline data from Phase 1/2 FORTITUDE™ trial, and initiated global confirmatory Phase 3 study Planned del-zota BLA submission at year end 2025 for DMD44 on track to be Avidity's first BLA submission On track for three potential BLA submissions over a 12-month period Strong balance sheet and cash runw...
Positive
Investors Business Daily
18 days ago
Avidity Biosciences stock rocketed Wednesday on a report Novartis made an attempt to buy the rare disease-focused biotech company.
More Avidity Biosciences Inc News

Company Profile

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) designed to treat a range of serious diseases. The company's lead product candidate is AOC 1001 for treatment of myotonic dystrophy type 1; and four other muscle programs, which focus on the treatment of muscle atrophy, duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, and Pompe disease. It utilizes its proprietary AOC platform to design, engineer, and develop therapeutics that combine tissue selectivity of monoclonal antibodies and precision of oligonucleotide therapies to access previously undruggable tissue and cell types, and target underlying genetic drivers of diseases. The company also has development programs that focuses on immune and other cell types. Avidity Biosciences, Inc. was founded in 2012 and is based in La Jolla, California.

Head office United States
CEO Sarah Boyce
Employees 391
Founded 2012
Website www.aviditybiosciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today